Differences between adipose tissue- derived mesenchymal stem cells and bone marrow-derived mesenchymal stem cells as regulators of the immune response

Stem Cells and Cancer Stem Cells, Volume 10: Therapeutic Applications in Disease and Injury

Volumn , Issue , 2013, Pages 71-84

  Kyurkchiev, Dobroslav ^a,b   Ivanova Todorova, Ekaterina ^a   Bochev, Ivan ^a   Mourdjeva, Milena ^c   Kyurkchiev, Stanimir ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^b Ob Gy Hospital Dr Shterev   (Bulgaria)

^c BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898878241     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-6262-6_7     Document Type: Chapter

References (32)

1. Bifari F, Pacelli L, Krampera M (2010) Immunological properties of embryonic and adult stem cells. World J Stem Cells 2:50-60
2. Blanco O, Tirado I, Munoz-Fernandez R, Abadía-Molina AC, García-Pacheco JM, Peňa J, Olivares EG (2008) Human decidual stromal cells express HLA-G effects of cytokines and decidualization. Hum Reprod 23:144-152
3. Bochev I, Kyurkchiev S (2009) Immunomodulatory effects of human bone marrow or adipose tissue derived mesenchymal stem cells on T-helper cell cytokine production in vitro. C R Acad Bulg Sci 62:1553-1558
4. Bochev I, Elmadjian G, Kyurkchiev D, Tzvetanov L, Altankova I, Tivchev P, Kyurkchiev S (2008) Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 32:384-393
5. Check JH, Dix E, Sansoucie L (2009) Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein. Med Hypotheses 72:87-90
6. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372
7. Curotto de Lafaille M, Lafaille J (2009) Natural and adaptive FoxP3+ Regulatory T cells: more of the same or a division of labor? Immunity 30:626-635
8. Dilioglou S, Cruse J, Lewis R (2003) Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells. Exp Mol Pathol 75:217-227
9. Djouad F, Charbonnier L, Bouffi C, Louis-Plence P, Bony C, Apparailly F, Cantos C, Jorgensen C, Noel D (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025-2032
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317
11. Favier B, Lemaoult J, Lesport E, Carosella ED (2010) ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J 24:689-699
12. Friedenstein A, Chailakhjan R, Lalykina K (1970) The development of fibroblast colonies in monolayer cultures of guineapig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403
13. Groh M, Maitra B, Szekely E, Koc O (2005) Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33:928-934
14. Hwang J, Shim S, Seok O, Lee H, Woo S, Kim B, Song H, Lee J, Park Y (2009) Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow. J Korean Med Sci 24:547-554
15. Ivanova-Todorova E, Bochev I, Mourdjeva M, Dimitrov R, Bukarev D, Kyurkchiev S, Tivchev P, Altunkova I, Kyurkchiev D (2009a) Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cell differentiation compared to bone-marrow-derived mesenchymal stem cells. Immunol Lett 126:37-42
16. Ivanova-Todorova E, Mourdjeva M, Kyurkchiev D, Bochev I, Stoyanova E, Dimitrov R, Timeva T, Yunakova M, Bukarev D, Shterev A, Tivchev P, Kyurkchiev S (2009b) HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. Am J Reprod Immunol 62:25-33
17. Jenhani F, Durand V, Ben Azouna N, Thallet S, Ben Othmen T, Bejaoui M, Domenech J (2011) Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells. Transplant Proc 43:639-643
18. Kyurkchiev D, Ivanova-Todorova E, Kyurkchiev S (2011) Effect of progesterone on mesenchymal stem cells. Stem Cell Regul Vitam Horm 87:217-238
19. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896
20. Mikoa E, Halasza M, Jericevic-Mulacb B, Wicherekc L, Arckd P, Aratuye G, Skret Magierlof J, Rukavinab D, Szekeres-Bartho J (2011) Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness. J Reprod Immunol 90:50-57
21. Nakagawa T, Tsuruoka M, Ogura H, Okuyama Y, Arima Y, Hirano T, Murakami M (2009) IL-6 positively regulates FoxP3+CD8+T cells in vivo. Int Immunol 22:129-139
22. Noël D, Caton D, Roche S, Bony C, Lehmann S, Casteilla L, Jorgensen C, Cousin B (2008) Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 5:1575-1584
23. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud L, Casteilla L, Blancher A (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129:118-129
24. Rasmusson I (2006) Immune modulation by mesenchymal stem cells. Exp Cell Res 312:2169-2179
25. Rasmusson I, Ringden O, Sundberg B, Le Blanc K (2003) Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76:1208-1213
26. Rizzo R, Lanzoni G, Stignani M, Campioni D, Alviano F, Ricci F, Tazzari PL, Melchiorri L, Scalinci SZ, Cuneo A, Bonsi L, Lanza F, Bagnara GP, Baricordi OR (2011) A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential. Cytotherapy 13:523-527
27. Sancho D, Gomez M, Sanchez-Madrid F (2005) CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 26:136-140
28. Tabera S, Pérez-Simón JA, Díez-Campelo M, Sánchez-Abarca LI, Blanco B, López A, Benito A, Ocio E, Sánchez-Guijo FM, Cañizo C, San Miguel JF (2008) The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93:1301-1309
29. Wallet M, Sen P, Tisch R (2005) Immunoregulation of dendritic cells. Clin Med & Res 3:166-175
30. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA (2006) Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 24:2582-2591
31. Yang S, Li W, Liu W, Gao C, Zhou B, Li S, Li Y, Kong Y (2006) IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis. Clin Immunol 121:63-73
32. Zuk P, Zhu M, Ashjian P, de Ugarte D, Huang J, Mizuno H, Alfonso Z, Fraser J, Benhaim P, Hedrick M (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295